Monopar Therapeutics Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Monopar Therapeutics quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Monopar Therapeutics Return On Equity for the quarter ending September 30, 2024 was -107 %, a 5.16% increase year-over-year.
  • Monopar Therapeutics annual Return On Equity for 2023 was -116 %, a 49.1% decline from 2022.
  • Monopar Therapeutics annual Return On Equity for 2022 was -77.8 %, a 89.4% decline from 2021.
  • Monopar Therapeutics annual Return On Equity for 2021 was -41.1 %, a 6% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -116 -38.2 -49.1% Jan 1, 2023 Dec 31, 2023
2022 -77.8 -36.7 -89.4% Jan 1, 2022 Dec 31, 2022
2021 -41.1 +2.62 +6% Jan 1, 2021 Dec 31, 2021
2020 -43.7 +16.4 +27.2% Jan 1, 2020 Dec 31, 2020
2019 -60 -19 -46.3% Jan 1, 2019 Dec 31, 2019
2018 -41 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.